Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Differential Interaction of the Staphylococcal Toxins Panton–Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors

András N. Spaan, Ariën Schiepers, Carla J. C. de Haas, Davy D. J. J. van Hooijdonk, Cédric Badiou, Hugues Contamin, François Vandenesch, Gérard Lina, Norma P. Gerard, Craig Gerard, Kok P. M. van Kessel, Thomas Henry and Jos A. G. van Strijp
J Immunol June 19, 2015, 1500604; DOI: https://doi.org/10.4049/jimmunol.1500604
András N. Spaan
*Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
†Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France;
‡Inserm, Unité 1111, 69007 Lyon, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ariën Schiepers
*Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla J. C. de Haas
*Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Davy D. J. J. van Hooijdonk
*Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cédric Badiou
†Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France;
‡Inserm, Unité 1111, 69007 Lyon, France;
§Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, 69007 Lyon, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugues Contamin
¶Cynbiose, 69280 Marcy l’Etoile, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Vandenesch
†Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France;
‡Inserm, Unité 1111, 69007 Lyon, France;
§Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, 69007 Lyon, France;
‖Centre National de Référence des Staphylocoques, Hospices Civils de Lyon, 69007 Lyon, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérard Lina
†Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France;
‡Inserm, Unité 1111, 69007 Lyon, France;
§Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, 69007 Lyon, France;
‖Centre National de Référence des Staphylocoques, Hospices Civils de Lyon, 69007 Lyon, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norma P. Gerard
#Ina Sue Perlmutter Laboratory, Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115; and
**Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Gerard
#Ina Sue Perlmutter Laboratory, Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kok P. M. van Kessel
*Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Henry
†Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France;
‡Inserm, Unité 1111, 69007 Lyon, France;
§Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, 69007 Lyon, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jos A. G. van Strijp
*Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Abstract

Staphylococcus aureus is well adapted to the human host. Evasion of the host phagocyte response is critical for successful infection. The staphylococcal bicomponent pore-forming toxins Panton–Valentine leukocidin LukSF-PV (PVL) and γ-hemolysin CB (HlgCB) target human phagocytes through interaction with the complement receptors C5aR1 and C5aR2. Currently, the apparent redundancy of both toxins cannot be adequately addressed in experimental models of infection because mice are resistant to PVL and HlgCB. The molecular basis for species specificity of the two toxins in animal models is not completely understood. We show that PVL and HlgCB feature distinct activity toward neutrophils of different mammalian species, where activity of PVL is found to be restricted to fewer species than that of HlgCB. Overexpression of various mammalian C5a receptors in HEK cells confirms that cytotoxicity toward neutrophils is driven by species-specific interactions of the toxins with C5aR1. By taking advantage of the species-specific engagement of the toxins with their receptors, we demonstrate that PVL and HlgCB differentially interact with human C5aR1 and C5aR2. In addition, binding studies illustrate that different parts of the receptor are involved in the initial binding of the toxin and the subsequent formation of lytic pores. These findings allow a better understanding of the molecular mechanism of pore formation. Finally, we show that the toxicity of PVL, but not of HlgCB, is neutralized by various C5aR1 antagonists. This study offers directions for the development of improved preclinical models for infection, as well as for the design of drugs antagonizing leukocidin toxicity.

Footnotes

  • This work was supported in part by grants from the European Commission (222718 to C.B., G.L., and F.V.), the Agence Nationale de la Recherche (to G.L., F.V., and T.H.), the Foundation Finovi (to T.H.), and the National Institute of Allergy and Infectious Diseases/National Institutes of Health (HL051366 to C.G.).

  • The online version of this article contains supplemental material.

  • Received March 13, 2015.
  • Accepted May 22, 2015.
  • Copyright © 2015 by The American Association of Immunologists, Inc.
Next
Back to top

In this issue

The Journal of Immunology: 209 (1)
The Journal of Immunology
Vol. 209, Issue 1
1 Jul 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Differential Interaction of the Staphylococcal Toxins Panton–Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Differential Interaction of the Staphylococcal Toxins Panton–Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors
András N. Spaan, Ariën Schiepers, Carla J. C. de Haas, Davy D. J. J. van Hooijdonk, Cédric Badiou, Hugues Contamin, François Vandenesch, Gérard Lina, Norma P. Gerard, Craig Gerard, Kok P. M. van Kessel, Thomas Henry, Jos A. G. van Strijp
The Journal of Immunology June 19, 2015, 1500604; DOI: 10.4049/jimmunol.1500604

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Differential Interaction of the Staphylococcal Toxins Panton–Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors
András N. Spaan, Ariën Schiepers, Carla J. C. de Haas, Davy D. J. J. van Hooijdonk, Cédric Badiou, Hugues Contamin, François Vandenesch, Gérard Lina, Norma P. Gerard, Craig Gerard, Kok P. M. van Kessel, Thomas Henry, Jos A. G. van Strijp
The Journal of Immunology June 19, 2015, 1500604; DOI: 10.4049/jimmunol.1500604
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The Capsid Protein of Nervous Necrosis Virus Antagonizes Host Type I IFN Production by a Dual Strategy to Negatively Regulate Retinoic Acid–Inducible Gene-I–like Receptor Pathways
  • Type I IFN Signaling Is Essential for Preventing IFN-γ Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection
  • MAVS Expression in Alveolar Macrophages Is Essential for Host Resistance against Aspergillus fumigatus
Show more INFECTIOUS DISEASE AND HOST RESPONSE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606